EUVIMEDEUVIMED entdecken
Crossref

Prognostic significance of a panel of two biomarkers (E-cadherin and CD105) in laryngeal cancer

Elvir Zvrko, Ljiljana Vuckovic, Miodrag Radunovic

Polish Journal of Pathology · 2023

DOI: 10.5114/pjp.2023.134316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polish Journal of Pathology, 2023. Verfasst von Elvir Zvrko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Clinical Centre of Montenegro, Podgorica, Montenegro. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the clinicopathologic significance of the combined immunohistochemical expression of the epithelial-mesenchymal transition marker E-cadherin and the angiogenesis marker CD105 in laryngeal squamous cell carcinoma and assess correlation of their expression. Eighty-five patients who underwent complete resection as primary treatment were selected for this study. E-cadherin and CD105 expression levels were determined by immunohistochemistry. The receiver operating curve approach was applied to determine the cut-off value and separate patients with high and low expression of markers. The high-risk group ("CD105 high" and "E-cadherin low" expression) showed statistically significant correlations with age less than 66 years (p = 0.039), advanced T-status (T3-4) (p = 0.046), aggressive TNM stage (stage III-IV) (p = 0.003) and locoregional recurrence of disease (p = 0.004). In the Kaplan-Meier analyses, the high-risk group had significantly worse prognoses than other risk groups (log-rank test 2 = 9.415, p = 0.024). Spearman's correlation coefficient analysis showed a nonsignificant negative correlation between the expression of E-cadherin and CD105 (rho = -0.073, p = 0.505). Simultaneous consideration of E-cadherin and CD105 is a simple panel of markers to determine aggressive tumour phenotype with a higher risk of disease recurrence in patients with laryngeal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsCarcinoma, Squamous CellHumansAgedPrognosisReceptors, Cell SurfaceEndoglinCadherinsBiomarkers, Tumor

Stichwörter der Autor:innen

CD105cancer.endoglinlarynxE-cadherin

Substanzen

Receptors, Cell SurfaceEndoglinCadherinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Clinical Centre of Montenegro, Podgorica, Montenegro.
  • Faculty of Medicine, University of Montenegro, Podgorica, Montenegro.
  • Department of Pathology, Clinical Centre of Montenegro, Podgorica, Montenegro.
  • Department of Surgery, Clinical Centre of Montenegro, Podgorica, Montenegro.

Zitieren

APA

Zvrko, E., Vuckovic, L., & Radunovic, M. (2023). Prognostic significance of a panel of two biomarkers (E-cadherin and CD105) in laryngeal cancer. Polish Journal of Pathology. https://doi.org/10.5114/pjp.2023.134316

Vancouver

Zvrko E, Vuckovic L, Radunovic M. Prognostic significance of a panel of two biomarkers (E-cadherin and CD105) in laryngeal cancer. Polish Journal of Pathology. 2023. doi:10.5114/pjp.2023.134316

BibTeX
@article{Zvrko2023,
  author = {Zvrko, Elvir and Vuckovic, Ljiljana and Radunovic, Miodrag},
  title = {Prognostic significance of a panel of two biomarkers (E-cadherin and CD105) in laryngeal cancer},
  journal = {Polish Journal of Pathology},
  year = {2023},
  doi = {10.5114/pjp.2023.134316}
}
Kostenlos starten →